The largest purchase of all time was on 2018-12-07 and amounted to 14800 shares of BioXcel Therapeutics, Inc. for $74,138.
The largest sale of all time was on 2013-07-02 and amounted to 122300 shares of Vertex Pharmaceuticals Incorporated for $9.76M.
No biography is available at this moment.
| 2019-08-23 | BioXcel Therapeutics, Inc. BTAI | director | 3,108 0.0101% | $4.67 | $14,514 | +119.3% | ||
| 2019-08-22 | BioXcel Therapeutics, Inc. BTAI | director | 13,292 0.0408% | $4.42 | $58,684 | +119.19% | ||
| 2019-08-21 | BioXcel Therapeutics, Inc. BTAI | director | 3,600 0.011% | $4.21 | $15,156 | +128.08% | ||
| 2018-12-07 | BioXcel Therapeutics, Inc. BTAI | director | 14,800 0.1076% | $5.01 | $74,138 | +93.45% | ||
| 2018-12-06 | BioXcel Therapeutics, Inc. BTAI | director | 2,790 0.0189% | $5.00 | $13,952 | +80.73% | ||
| 2018-12-04 | BioXcel Therapeutics, Inc. BTAI | director | 8,014 0.058% | $5.13 | $41,088 | +88.27% | ||
| 2014-06-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0033% | $68.31 | $512,352 | +70.02% | |
| 2014-05-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $67.45 | $505,849 | +64.85% | |
| 2014-04-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0031% | $61.63 | $462,207 | +70.56% | |
| 2014-03-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $78.29 | $587,145 | +26.46% | |
| 2014-02-18 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $82.59 | $619,442 | +15.5% | |
| 2014-01-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $78.67 | $590,025 | +16.07% | |
| 2013-12-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $64.69 | $485,142 | +30.91% | |
| 2013-12-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 2,900 0.0013% | $65.48 | $189,892 | +29.09% | |
| 2013-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $62.61 | $469,606 | +27.56% | |
| 2013-10-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $73.25 | $549,365 | +5.88% | |
| 2013-09-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0033% | $77.22 | $579,160 | -0.61% | |
| 2013-08-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0033% | $77.41 | $580,560 | -1.94% | |
| 2013-07-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 7,500 0.0032% | $86.34 | $647,517 | -13% | |
| 2013-07-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global R&D, CSO | 122,300 0.0532% | $79.80 | $9.76M | -5.09% |